Search results
Moderna Stock Seesaws After The FDA Throws It A Curveball
Investor's Business Daily· 6 days agoThe FDA was due to make a decision by May 12. Moderna emphasized the FDA has not said it found any...
If You'd Invested $1,000 in Moderna Stock 5 Years Ago, Here's How Much You'd Have Today
Motley Fool via Yahoo Finance· 7 days agoShares nearly quintupled in calendar 2020, and ultimately rallied nearly 500% from 2019's low to...
Cramer's Lightning Round: 'I'm a believer' in Moderna
CNBC· 1 day ago"Mad Money" host Jim Cramer rings the lightning round bell, which means he's giving his answers to...
Moderna and OpenAI Are Teaming Up, but Does That Make the Stock a Buy?
Motley Fool via Yahoo Finance· 4 days agoThat'd be a big green flag for the stock, and in due time, it might become a competitive advantage...
Moderna Stock Rebounds From Its RSV Vaccine Fallout — Is It A Buy, Again?
Investor's Business Daily· 2 days agoModerna stock tumbled — and then rebounded — after the Food and Drug Administration delayed its RSV...
Investors Heavily Search Moderna, Inc. (MRNA): Here is What You Need to Know
Zacks via Yahoo Finance· 3 days agoModerna (MRNA) has received quite a bit of attention from Zacks.com users lately. Therefore, it is...
Is This a Setback for Moderna?
The Motley Fool via AOL· 2 days agoModerna said the U.S. Food and Drug Administration (FDA) wouldn't be able to make that deadline and that it required a few more weeks to consider the...
Novavax, Nvidia, Sweetgreen rise premarket; Moderna, Yelp fall By Investing.com
Investing.com· 6 days agoNovavax, Nvidia, Sweetgreen rise premarket; Moderna, Yelp fall
Wealthspire Advisors LLC Has $301,000 Stock Position in Moderna, Inc. (NASDAQ:MRNA)
ETF DAILY NEWS· 4 days agoThe institutional investor owned 3,028 shares of the company’s stock after selling 261 shares during the quarter. Wealthspire Advisors LLC’s holdings in Moderna< ...
Jim Cramer: This Industrial Company Is ‘Absolutely Terrific’, Recommends Buying Modine Manufacturing...
Benzinga· 20 hours agoOn CNBC's “Mad Money Lightning Round,” Jim Cramer believes in Moderna, Inc. On May 14, Evercore ISI Group analyst Cory Kasimov initiated coverage on Moderna